Although various immune and metabolic pathways have been proposed in late-onset preeclampsia (LO-PE), direct evidence for specific processes—such as Allograft Rejection, Estrogen Response, or Glycolysis—and for genes like HLA-G, IL17RB, and KLRC4 remains limited. The gene discussed is HLA-G; the disease is preeclampsia.